Dr. Zhan graduated from the University of Western Ontario, Canada, with a Ph.D. degree in molecular biology. He did his postdoctoral training in human genomics at the University of Victoria. He later accepted the positions of senior scientist and project supervisor the Oak Ridge National Laboratory to work on drosophila and human genome projects for the Department of Energy Human Genome Program and Celera. In 2003, Dr. Zhan joined the National Institute on Aging as chief of the bioinformatics unit, where he founded the bioinformatics core facility and developed a research program in bioinformatics and systems biology of stem cells. His
Dr. Zhan graduated from the University of Western Ontario, Canada, with a Ph.D. degree in molecular biology. He did his postdoctoral training in human genomics at the University of Victoria. He later accepted the positions of senior scientist and project supervisor the Oak Ridge National Laboratory to work on drosophila and human genome projects for the Department of Energy Human Genome Program and Celera. In 2003, Dr. Zhan joined the National Institute on Aging as chief of the bioinformatics unit, where he founded the bioinformatics core facility and developed a research program in bioinformatics and systems biology of stem cells. His research uses computational biology to assess bio-complexity, and tailors the functions and behavior of cells for therapeutic applications with approaches based on genomics and systems biology investigation. His projects include multi-scale modeling of cancer stem cells and cancer development, and therapeutic discovery of cancer and age-related diseases.
Dr. Maes is a highly cited author and published more than 600 scientific papers. The work of Dr. Maes covers phenomenological and epidemiological aspects of mood disorders and the supra-multi-disciplinary field of 'pathway and drug discovery processes' in depression, bipolar disorder, schizophrenia, ME/CFS and more particularly the immune-inflammatory pathways and its connections and sequels. Dr. Maes is a clinician and translational scientist whose works ranges from epidemiological and clinical research projects, case-control studies and pharmacological trials, to rodent and molecular experiments.
Dr. Maes is a highly cited author and published more than 600 scientific papers. The work of Dr. Maes covers phenomenological and epidemiological aspects of mood disorders and the supra-multi-disciplinary field of 'pathway and drug discovery processes' in depression, bipolar disorder, schizophrenia, ME/CFS and more particularly the immune-inflammatory pathways and its connections and sequels. Dr. Maes is a clinician and translational scientist whose works ranges from epidemiological and clinical research projects, case-control studies and pharmacological trials, to rodent and molecular experiments.
Dr. Li earned his M.S. in statistical genetics in China and Ph.D. in molecular genetics at the University of Nottingham in the United Kingdom. He joined the UCLA faculty in 2007, and currently serve as the Director of JCCC Genomics Shared Resource/UCLA Clinical Microarray Core. His research focuses on the identification and characterization of genetic variations that affect complex diseases. He uses an integrated genomic approach to investigate global mRNA/miRNA expression, copy number variation, single nucleotide polymorphism and DNA-protein interaction by primarily using microarray/NGS-based technologies for initial screening and siRNA/miRNA-mediated technologies for functional screening.
Dr. Li earned his M.S. in statistical genetics in China and Ph.D. in molecular genetics at the University of Nottingham in the United Kingdom. He joined the UCLA faculty in 2007, and currently serve as the Director of JCCC Genomics Shared Resource/UCLA Clinical Microarray Core. His research focuses on the identification and characterization of genetic variations that affect complex diseases. He uses an integrated genomic approach to investigate global mRNA/miRNA expression, copy number variation, single nucleotide polymorphism and DNA-protein interaction by primarily using microarray/NGS-based technologies for initial screening and siRNA/miRNA-mediated technologies for functional screening.
Dr. Rakesh K. Srivastava is a professor in the University of Missouri, Kansas City School of Medicine. His research interests include Cancer therapy, prevention, stem cell, Nano technology, drug discovery and development, cell signaling, metastasis and apoptosis.
The focus of our research interest is on the molecular elucidation of human disease with a special focus on growth and neuronal disorders. To uncover the basic mechanisms on the causes of these disorders, our work employs different cell culture and animal models as well as differentiated stem cells. We would like to understand how mutations correlate with disease, how genes are regulated and how they contribute to differentiation and development. By integrating genetic, molecular, biochemical and cell biological approaches, the basic understanding and function of these proteins and their roles in the relevant networks will be established.
The focus of our research interest is on the molecular elucidation of human disease with a special focus on growth and neuronal disorders. To uncover the basic mechanisms on the causes of these disorders, our work employs different cell culture and animal models as well as differentiated stem cells. We would like to understand how mutations correlate with disease, how genes are regulated and how they contribute to differentiation and development. By integrating genetic, molecular, biochemical and cell biological approaches, the basic understanding and function of these proteins and their roles in the relevant networks will be established.
Dr. Kreiswirth is the founding director of the PHRI TB Center, a Professor of Medicine at Rutgers and has an adjunct faculty position in the Department of Medicine at New York University, is a senior lecturer at the Mailman School of Public Health at Columbia University and a visiting scientist at the Museum of Natural History. The Kreiswirth laboratory is focused on nosocomial infections and the emergence of antibiotic resistance and the research aims include the development of rapid genotyping methods for both molecular epidemiologic studies and to advance infection control strategies.
Dr. Kreiswirth is the founding director of the PHRI TB Center, a Professor of Medicine at Rutgers and has an adjunct faculty position in the Department of Medicine at New York University, is a senior lecturer at the Mailman School of Public Health at Columbia University and a visiting scientist at the Museum of Natural History. The Kreiswirth laboratory is focused on nosocomial infections and the emergence of antibiotic resistance and the research aims include the development of rapid genotyping methods for both molecular epidemiologic studies and to advance infection control strategies.
Dr. Kumar is currently a Professor of Biochemistry at The Commonwealth Medical College (TCMC), Scranton, PA, USA. He received his Ph.D. from University of Lucknow, Lucknow, India, and post doctoral training at University of Texas Medical Branch (UTMB), Galveston, TX, USA. Before moving to TCMC, he held position of Associate Professor in the Department of Internal Medicine at UTMB. His area of research is focused on the therapeutic targeting of the steroid hormone receptors (SHRs) for endocrine-related diseases. Currently, his laboratory is integrating multiple complementary state-of-art technologies add a new translational goal of targeting SHRs intrinsically disordered N-terminal activation function
Dr. Kumar is currently a Professor of Biochemistry at The Commonwealth Medical College (TCMC), Scranton, PA, USA. He received his Ph.D. from University of Lucknow, Lucknow, India, and post doctoral training at University of Texas Medical Branch (UTMB), Galveston, TX, USA. Before moving to TCMC, he held position of Associate Professor in the Department of Internal Medicine at UTMB. His area of research is focused on the therapeutic targeting of the steroid hormone receptors (SHRs) for endocrine-related diseases. Currently, his laboratory is integrating multiple complementary state-of-art technologies add a new translational goal of targeting SHRs intrinsically disordered N-terminal activation function domain, AF1 as a novel therapeutic strategy that could provide additional selectivity needed to target cell-tissue specific gene regulations in current endocrine-based therapies.
Dr. Hoh is currently a professor of molecular and population genetics at the Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia. He is currently the Director for the Centre of Excellence in Research, Value Innovation and Entrepreneurship, a centre that anchors of the research portfolio of the university. He received his PhD (Genetics) in 2006. Dr Hoh studies various applications of SNPs array and the newly emerged genetic marker - Copy Number Variation (CNV). His major research interest is on genetic susceptibility of complex diseases, in particular infectious diseases and cardiovascular diseases. Besides, he is also interested
Dr. Hoh is currently a professor of molecular and population genetics at the Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia. He is currently the Director for the Centre of Excellence in Research, Value Innovation and Entrepreneurship, a centre that anchors of the research portfolio of the university. He received his PhD (Genetics) in 2006. Dr Hoh studies various applications of SNPs array and the newly emerged genetic marker - Copy Number Variation (CNV). His major research interest is on genetic susceptibility of complex diseases, in particular infectious diseases and cardiovascular diseases. Besides, he is also interested to study the genetic architecture and local adaptation of the indigenous populations in Southeast Asia.
Dr. Dongren Ren, Ph.D., Project Director, Research Associate in Biology and Psychology Department of Nebraska University of Nebraska at Omaha, Nebraska, USA; Associate Professor in Jiangxi Agricultural University, Nanchang, China. I received my PhD (animal genetics, breeding and reproduction) in 2008. My research focused on the genetic and epigenetic mechanisms underlying reproduction, growth, development, behavior, and evolution. I have published multiple papers in peer-reviewed journals and served as a reviewer for many leading journals. My research interests include Genetics; Epigenetics; Evolution; Genomics.
Dr. Dongren Ren, Ph.D., Project Director, Research Associate in Biology and Psychology Department of Nebraska University of Nebraska at Omaha, Nebraska, USA; Associate Professor in Jiangxi Agricultural University, Nanchang, China. I received my PhD (animal genetics, breeding and reproduction) in 2008. My research focused on the genetic and epigenetic mechanisms underlying reproduction, growth, development, behavior, and evolution. I have published multiple papers in peer-reviewed journals and served as a reviewer for many leading journals. My research interests include Genetics; Epigenetics; Evolution; Genomics.
Dr. Elvira Grandone, MD, is a Board certified Obstetrician and Gynaecologist with over 25 years of extensive experience in the field of molecular biology and genetics. Furthermore, she obtained a PhD in Biology and Vascular Physiopathology. Dr. Grandone has conducted many clinical research trials serving as principal or local investigator. She has been involved in the compilation of guidelines and consensus conference (ref 1-5). She has been in the Executive Committee of the Italian Society of Thrombosis and Haemostasis and is member of the review board meeting in Mainz (Germany) for the 'Integraed Research and Treatment Centres-IFB'
Dr. Elvira Grandone, MD, is a Board certified Obstetrician and Gynaecologist with over 25 years of extensive experience in the field of molecular biology and genetics. Furthermore, she obtained a PhD in Biology and Vascular Physiopathology. Dr. Grandone has conducted many clinical research trials serving as principal or local investigator. She has been involved in the compilation of guidelines and consensus conference (ref 1-5). She has been in the Executive Committee of the Italian Society of Thrombosis and Haemostasis and is member of the review board meeting in Mainz (Germany) for the 'Integraed Research and Treatment Centres-IFB' (FUNDING BY THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH). Her research interest include: thrombophilia, venous thrombosis, pregnancy complications, genetic predisposition to multifactorial diseases, somatic mutations involved in the development of myeloproliferative neoplasms, genetic studies on rare bleeding disorders. Recent Research Interests: Research of new risk factors for pregnancy complications/venous thromboembolism and investigation of placentae from women with adverse obstetric outcomes (mainly studies of gene expression) is currently being carried out. Recent original data have been obtained in the field of annexin A5.
Dr. Elliott is the Chief Scientific Officer of Research and Development at Ambry Genetics where he oversees the clinical development and validation of all CLIA/CAP regulated diagnostic assays. Major areas of interest include target enrichment technologies and next-generation sequencing. Dr. Elliott received his undergraduate degree in Biology from Franklin and Marshall College and went on to do his Genetics Ph.D. training at Thomas Jefferson University and Johns Hopkins University School of Medicine. He conducted his postdoctoral training in the cancer stem cell department at the Novartis Institute for Functional Genomics in San Diego, CA where he studied potential drug targets
Dr. Elliott is the Chief Scientific Officer of Research and Development at Ambry Genetics where he oversees the clinical development and validation of all CLIA/CAP regulated diagnostic assays. Major areas of interest include target enrichment technologies and next-generation sequencing. Dr. Elliott received his undergraduate degree in Biology from Franklin and Marshall College and went on to do his Genetics Ph.D. training at Thomas Jefferson University and Johns Hopkins University School of Medicine. He conducted his postdoctoral training in the cancer stem cell department at the Novartis Institute for Functional Genomics in San Diego, CA where he studied potential drug targets for chemotherapeutic resistance.
Dr. Stephanie Fliedner heads the Research Lab for Neuroendocrine Oncology at the 1st Medical Department of the University Medical Center Schleswig-Holstein, Germany. Her main focus is the molecular classification and stratification of pheochromocytoma and paraganglioma with different genotypes and the molecular basis of malignancy using microarray and proteomics approaches. She trained at the Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health. Since 2012 she has been an invested board member of 'Young Active Research in Endocrinology' (YARE). She serves as YARE Treasurer since 2014.
Dr. Stephanie Fliedner heads the Research Lab for Neuroendocrine Oncology at the 1st Medical Department of the University Medical Center Schleswig-Holstein, Germany. Her main focus is the molecular classification and stratification of pheochromocytoma and paraganglioma with different genotypes and the molecular basis of malignancy using microarray and proteomics approaches. She trained at the Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health. Since 2012 she has been an invested board member of 'Young Active Research in Endocrinology' (YARE). She serves as YARE Treasurer since 2014.
My early graduate work (Univ. Connecticut) centered on gaining a deep understanding of the neural connections and their neurochemical identities between the brain and the sensory cells of the inner ear responsible for encoding auditory stimuli. During my postdoctoral tenure (The Salk Institute for Biological Studies), my work broadened to further resolve the molecular nature of the cells that communicated with the hair cells and the receptors that were involved in this signaling. My lab investigates gene expression and cell signaling cascades involved in both descending neural input directed to hair cells, as well as a local peptide based paracrine
My early graduate work (Univ. Connecticut) centered on gaining a deep understanding of the neural connections and their neurochemical identities between the brain and the sensory cells of the inner ear responsible for encoding auditory stimuli. During my postdoctoral tenure (The Salk Institute for Biological Studies), my work broadened to further resolve the molecular nature of the cells that communicated with the hair cells and the receptors that were involved in this signaling. My lab investigates gene expression and cell signaling cascades involved in both descending neural input directed to hair cells, as well as a local peptide based paracrine signaling system within the cochlea that replicates the well known hypothalamic-pituitary adrenal axis. My interests lie in understanding the maturation and regulation of synaptic structure and strength within the inner ear, the development and maintenance of acoustic sensitivity and related susceptibility to noise-induced hearing loss, and the effects of stress and steroid hormone signaling on these processes.
Dr. Xiang Yang Zhang is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at The University of Texas Health Science Center Houston. He also holds the position as the Director of the Psychiatry Research Center, Beijing HuiLongGuan Hospital, Peking University. Dr. Zhang has focused on schizophrenia and drug dependence/addiction research throughout his career. His areas of expertise include comprehensive studies in clinical symptom, cognition, biomarkers, genetics and clinical psychopharmacology. The goal of his research is to examine and understand the mechanisms underlying schizophrenia and drug dependence/addiction in order to build rational treatments for the illness.
Dr. Xiang Yang Zhang is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at The University of Texas Health Science Center Houston. He also holds the position as the Director of the Psychiatry Research Center, Beijing HuiLongGuan Hospital, Peking University. Dr. Zhang has focused on schizophrenia and drug dependence/addiction research throughout his career. His areas of expertise include comprehensive studies in clinical symptom, cognition, biomarkers, genetics and clinical psychopharmacology. The goal of his research is to examine and understand the mechanisms underlying schizophrenia and drug dependence/addiction in order to build rational treatments for the illness. One set his studies focus is genetics of psychiatric illness. They study a range of behavioral phenotypes including schizophrenia and nicotine dependence.
Following an interest in bacterial pathogenesis he developed while studying the intracellular transport of Brucella abortus when he was a graduate student, Dr. Aballay moved to Boston to join the Ausubel laboratory at Harvard Medical School. Dr. Aballay moved to Durham in 2002 to join the Department of Molecular Genetics and Microbiology, where his studies genetic basis of innate immunity. His laboratory takes advantage of the compromise between complexity and genetic tractability of the nematode Caenorhabditis elegans. The focus of the laboratory is to use C. elegans as a host to screen thousands of bacterial clones from mutagenized libraries to
Following an interest in bacterial pathogenesis he developed while studying the intracellular transport of Brucella abortus when he was a graduate student, Dr. Aballay moved to Boston to join the Ausubel laboratory at Harvard Medical School. Dr. Aballay moved to Durham in 2002 to join the Department of Molecular Genetics and Microbiology, where his studies genetic basis of innate immunity. His laboratory takes advantage of the compromise between complexity and genetic tractability of the nematode Caenorhabditis elegans. The focus of the laboratory is to use C. elegans as a host to screen thousands of bacterial clones from mutagenized libraries to identify novel virulence factors and to address how they alter host signaling pathways. Since several components of innate immunity are conserved among different organisms throughout evolution, his group is also exploiting the genetic and genomic resources available for C. elegans to study the basis of the immune response.
Dr. McClain is Research Associate Professor in the Health Management and Policy Department and the Institute on Disability at the University of New Hampshire. She has a strong background in applied research, screening, and public health. The focus of her career as an epidemiologist has been on the evaluation and implementation of evidence-based practice in medicine, and more specifically genetic testing and medical screening. Dr. McClain works closely with each of the six New England states′ Title V and Newborn Screening Public Health Programs to assess needs, implement change, and evaluate newborn screening program results. She currently is
Dr. McClain is Research Associate Professor in the Health Management and Policy Department and the Institute on Disability at the University of New Hampshire. She has a strong background in applied research, screening, and public health. The focus of her career as an epidemiologist has been on the evaluation and implementation of evidence-based practice in medicine, and more specifically genetic testing and medical screening. Dr. McClain works closely with each of the six New England states′ Title V and Newborn Screening Public Health Programs to assess needs, implement change, and evaluate newborn screening program results. She currently is PI of a grant to implement critical congenital heart disease newborn screening in five New England states. Another area of interest is hereditary cancers, specifically how to ensure that those who are at risk are identified and receive genetic services. Dr. McClain also has extensive experience in health services research using administrative claims data, vital records, and other large data sets.
Dr. Tang is the Associate Director of Clinical Genomics at Ambry Genetics. She is board certified in Clinical Molecular Genetics by the American Board of Medical Genetics and her current interests focus on utilizing whole exome sequencing to diagnose patients with rare genetic disorders and discover novel Mendelian genes in a clinical setting. Her expertise also includes molecular genetics and diagnosis of mitochondrial disorders.
Dr. Tang is the Associate Director of Clinical Genomics at Ambry Genetics. She is board certified in Clinical Molecular Genetics by the American Board of Medical Genetics and her current interests focus on utilizing whole exome sequencing to diagnose patients with rare genetic disorders and discover novel Mendelian genes in a clinical setting. Her expertise also includes molecular genetics and diagnosis of mitochondrial disorders.
Dr. Sudha obtained her PhD from the University of London, Kings College in 2000. During this period, she joined a team of scientists at Aventis Pharma. Sudha was recruited by Professor Shannon (Gene Expression and Epigenomics Group) as a postdoctoral fellow to JCSMR, ANU in 2000. In 2003 she was appointed as a research fellow (Level B) and in 2009, Sudha was appointed Team Leader of the Immune Regulation & Nuclear Dynamics Group at JCSMR, ANU. Sudha moved to the University of Canberra in 2010 as an Associate Professor in Molecular & Cellular Biology within the Health Reseach Institute.
Dr. Sudha obtained her PhD from the University of London, Kings College in 2000. During this period, she joined a team of scientists at Aventis Pharma. Sudha was recruited by Professor Shannon (Gene Expression and Epigenomics Group) as a postdoctoral fellow to JCSMR, ANU in 2000. In 2003 she was appointed as a research fellow (Level B) and in 2009, Sudha was appointed Team Leader of the Immune Regulation & Nuclear Dynamics Group at JCSMR, ANU. Sudha moved to the University of Canberra in 2010 as an Associate Professor in Molecular & Cellular Biology within the Health Reseach Institute. Sudha has extensive experience in transcriptional biology and genomic technologies that spans both pharmaceutical and academic settings. The primary focus of her research group has been to unravel complex epigenetic-signatures in transcription programs in the context of the immune system, as well as to understand the deregulatory mechanisms operating in cancer settings. Her research interests include Epigenetic regulation, Inducible gene regulation, Nuclear Kinases, Breast cancer and cancer stem cells, Immune System.
Eduardo Nagore, is an Associate professor at the Universidad Catolica of Valencia, Spain. Dermatologist since 1997, received his Ph.D. (in Medical Sciences) from the Universitat de Valencia in 2007. His clinical practice takes place at the Instituto Valenciano de Oncologia, an oncology center where has developed most of his professional career. His research interest and area of expertise is skin cancer, particularly melanoma and, in particular, genetic epidemiology.
Eduardo Nagore, is an Associate professor at the Universidad Catolica of Valencia, Spain. Dermatologist since 1997, received his Ph.D. (in Medical Sciences) from the Universitat de Valencia in 2007. His clinical practice takes place at the Instituto Valenciano de Oncologia, an oncology center where has developed most of his professional career. His research interest and area of expertise is skin cancer, particularly melanoma and, in particular, genetic epidemiology.
Dr. Asangla Ao received her PhD in Genetics and Biometry from UCL, London, UK and her postdoctoral training in the USA. She then worked as a senior research scientist in Royal Postgraduate medical school at Hammersmith hospital, London, UK where she performed pioneering work in the field of Preimplantation Genetic Diagnosis (PGD). At present, Dr. Ao is the Scientific Director of PGD programme at McGill University Health center- Reproductive Centre and an Associate Professor in the Department of Obstetrics and Gynecology and Department of Human Genetics. Dr. Ao has published over 100 research articles, book chapters and abstracts and has
Dr. Asangla Ao received her PhD in Genetics and Biometry from UCL, London, UK and her postdoctoral training in the USA. She then worked as a senior research scientist in Royal Postgraduate medical school at Hammersmith hospital, London, UK where she performed pioneering work in the field of Preimplantation Genetic Diagnosis (PGD). At present, Dr. Ao is the Scientific Director of PGD programme at McGill University Health center- Reproductive Centre and an Associate Professor in the Department of Obstetrics and Gynecology and Department of Human Genetics. Dr. Ao has published over 100 research articles, book chapters and abstracts and has presented over 50 invited lectures both nationally and internationally. Dr Ao served as an associate editor for the journal Molecular Human reproduction. Dr. Ao′s research interest includes origin and mechanism of chromosome abnormality in human embryos, gene expression in mammalian preimplantation embryos and preimplantation genetic diagnosis.
Meng Ma, Associate professor from Anhui University, with a focus on data mining analysis on genome data. Meng obtained a PhD in computer science from University of Science and Technology of China. After that, Meng moved to University of North Carolina at Chapel Hill to receive postdoctoral research training at Prof.Zefeng Wang Laboratory, mainly focusing on gene alternative splicing regulatory mechanism study. Most recently, Meng worked on personal disease risk prediction. Research Interests include Bioinformatics, Data mining.
Meng Ma, Associate professor from Anhui University, with a focus on data mining analysis on genome data. Meng obtained a PhD in computer science from University of Science and Technology of China. After that, Meng moved to University of North Carolina at Chapel Hill to receive postdoctoral research training at Prof.Zefeng Wang Laboratory, mainly focusing on gene alternative splicing regulatory mechanism study. Most recently, Meng worked on personal disease risk prediction. Research Interests include Bioinformatics, Data mining.
Dr. Jakubowskiis an Adjunct Professor of Microbiology, Biochemistry and Molecular Genetics at Rutgers University, New Jersey Medical School, Newark, NJ, USA, a Professor at the Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, and a Professor at the Department of Biochemistry and Biotechnology, University of Life Sciences, Poznan, Poland. His work focuses on the fidelity of amino acid selection by tRNA synthetases, error-editing mechanisms in protein biosynthesis, mechanisms of homocysteine incorporation into protein, and the role homocysteine-containing proteins in cardiovascular and neurodegenerative diseases. He has served on the National Institute of Health, American Cancer Society, American Heart Association, and
Dr. Jakubowskiis an Adjunct Professor of Microbiology, Biochemistry and Molecular Genetics at Rutgers University, New Jersey Medical School, Newark, NJ, USA, a Professor at the Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, and a Professor at the Department of Biochemistry and Biotechnology, University of Life Sciences, Poznan, Poland. His work focuses on the fidelity of amino acid selection by tRNA synthetases, error-editing mechanisms in protein biosynthesis, mechanisms of homocysteine incorporation into protein, and the role homocysteine-containing proteins in cardiovascular and neurodegenerative diseases. He has served on the National Institute of Health, American Cancer Society, American Heart Association, and National Science Center (Poland) Study Sections.
Dr. Haruki Hasegawa is a molecular cell biologist studying the processes of in vivo protein folding and the intracellular protein trafficking events in mammalian cell systems. He focuses on elucidating cargo-specific biosynthetic mechanisms for broad classes of therapeutically important proteins, secretory proteins, mAbs, membrane-anchored proteins, organelle-resident proteins, cytosolic proteins, peripheral membrane proteins, ECM-associated proteins, etc. Haruki is currently a Principal Scientist/Group Leader in Amgen′s Biologics Therapeutic Discovery Department. He works closely with 'disease area' specialists, geneticists, and technology experts to advance early exploratory drug discovery projects from target validation and proof-of-concept studies to lead selection and optimization.
Dr. Haruki Hasegawa is a molecular cell biologist studying the processes of in vivo protein folding and the intracellular protein trafficking events in mammalian cell systems. He focuses on elucidating cargo-specific biosynthetic mechanisms for broad classes of therapeutically important proteins, secretory proteins, mAbs, membrane-anchored proteins, organelle-resident proteins, cytosolic proteins, peripheral membrane proteins, ECM-associated proteins, etc. Haruki is currently a Principal Scientist/Group Leader in Amgen′s Biologics Therapeutic Discovery Department. He works closely with 'disease area' specialists, geneticists, and technology experts to advance early exploratory drug discovery projects from target validation and proof-of-concept studies to lead selection and optimization.
Dr. Sukesh R. Bhaumik has started his own research program as an Assistant Professor in the Department of Biochemistry and Molecular Biology at Southern Illinois University School of Medicine, USA, in 2003. He is currently an Associate Professor in the Department of Biochemistry and Molecular Biology at Southern Illinois University School of Medicine. His research is focused on the regulation of eukaryotic gene expression and maintenance of active genome integrity with implications in human diseases, Transcription, mRNA processing and export, chromatin structure, and DNA repair.
Dr. Sukesh R. Bhaumik has started his own research program as an Assistant Professor in the Department of Biochemistry and Molecular Biology at Southern Illinois University School of Medicine, USA, in 2003. He is currently an Associate Professor in the Department of Biochemistry and Molecular Biology at Southern Illinois University School of Medicine. His research is focused on the regulation of eukaryotic gene expression and maintenance of active genome integrity with implications in human diseases, Transcription, mRNA processing and export, chromatin structure, and DNA repair.
A/Prof Helena Richardson is a NHMRC Senior Research Fellow level B and a Group Leader at the Peter MacCallum Cancer Centre (PMCC), Melbourne Australia (Oct 2000-14). She uses the vinegar fly, Drosophila, to model tumourigenesis, with the vision of understanding how regulators of cell polarity and the actin cytoskeleton impact on cell signalling and cell proliferation, a field in which she is internationally recognised. She collaborates with mammalian researchers to translate her findings to mouse and human cancer models.
A/Prof Helena Richardson is a NHMRC Senior Research Fellow level B and a Group Leader at the Peter MacCallum Cancer Centre (PMCC), Melbourne Australia (Oct 2000-14). She uses the vinegar fly, Drosophila, to model tumourigenesis, with the vision of understanding how regulators of cell polarity and the actin cytoskeleton impact on cell signalling and cell proliferation, a field in which she is internationally recognised. She collaborates with mammalian researchers to translate her findings to mouse and human cancer models.
Dr. Chen Wang is a Research Associate and Assistant Professor in the Division of Bioinformatics and Biostatistics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. He completed his Ph.D. in Electrical and Computer Engineering, Virginia Polytechnic Institute and State University, in 2011. His scientific background is in statistical machine learning, bioinformatics and computational Biology, with bioinformatics emphasis on sequencing-based tool development and a special disease interest in gynecologic cancers. Dr. Chen Wang is a Principal investigator for the project 'Development of integrative methods for discovering clinical outcome-associated subtype discovery' in Ovarian SPORE pilot project
Dr. Chen Wang is a Research Associate and Assistant Professor in the Division of Bioinformatics and Biostatistics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. He completed his Ph.D. in Electrical and Computer Engineering, Virginia Polytechnic Institute and State University, in 2011. His scientific background is in statistical machine learning, bioinformatics and computational Biology, with bioinformatics emphasis on sequencing-based tool development and a special disease interest in gynecologic cancers. Dr. Chen Wang is a Principal investigator for the project 'Development of integrative methods for discovering clinical outcome-associated subtype discovery' in Ovarian SPORE pilot project and co-investigators of multiple NIH funded projects.
Dr. Peter Antinozzi has been a member of the Wake Forest School of Medicine faculty since 2007. He currently holds appointments in the Departments of Biochemistry, Internal Medicine and Genomics and Personalized Medicine. His expertise includes diabetes research serving as a Principal Investigator on grants awarded by the JDRF, ADA, NIH, and industry sponsors. Projects have a special emphasis on genomics, next-gen sequencing, high content/throughput cellular imaging and regenerative medicine approaches. As an instructor and program/curriculum director, Dr. Antinozzi has lectured in over 15 undergraduate and graduate level courses. Lectur topics range across physiology (Medical School Core Curriculum), cell
Dr. Peter Antinozzi has been a member of the Wake Forest School of Medicine faculty since 2007. He currently holds appointments in the Departments of Biochemistry, Internal Medicine and Genomics and Personalized Medicine. His expertise includes diabetes research serving as a Principal Investigator on grants awarded by the JDRF, ADA, NIH, and industry sponsors. Projects have a special emphasis on genomics, next-gen sequencing, high content/throughput cellular imaging and regenerative medicine approaches. As an instructor and program/curriculum director, Dr. Antinozzi has lectured in over 15 undergraduate and graduate level courses. Lectur topics range across physiology (Medical School Core Curriculum), cell biology (receptor signaling, metabolism), statistics, bioinformatics, and high-throughput technologies. Prior to joining Wake Forest, Dr Antinozzi was a faculty member in the Department of Physiology and Cellular Biophysics at Columbia University in New York City. He received his PhD in Cellular and Molecular Biology at University of Texas Southwestern Medical Center in Dallas, and continued training with post-doctoral fellowships at University of Geneva (Switzerland) and Memorial Sloan Kettering Cancer Center in New York City. His research interests include aging, cell growth, differentiation,d, diabetes, hypertension
Dr. Huang is an Assistant Professor of biostatistics in the Department of Epidemiology and Biostatistics at the University of Georgia. His research interests include Statistical Genetics and Genetic epidemiology, Statistical Machine Learning, Bioinformatics, Biostatistics, and Collaborative Research. The main goal of his research is to develop and evaluate statistical methodologies and apply them to solve research problems in the area of genetics, biology and medical science. He has expertise in study design, data analysis, computational methods, and software development. Research interest include Statistical Genetics and Genetic Epidemiology, Statistical machine learning and data mining, Clinical Trial, Linear Mixed Models, Longitudinal Data
Dr. Huang is an Assistant Professor of biostatistics in the Department of Epidemiology and Biostatistics at the University of Georgia. His research interests include Statistical Genetics and Genetic epidemiology, Statistical Machine Learning, Bioinformatics, Biostatistics, and Collaborative Research. The main goal of his research is to develop and evaluate statistical methodologies and apply them to solve research problems in the area of genetics, biology and medical science. He has expertise in study design, data analysis, computational methods, and software development. Research interest include Statistical Genetics and Genetic Epidemiology, Statistical machine learning and data mining, Clinical Trial, Linear Mixed Models, Longitudinal Data Analysis, Meta-analysis, Bayesian Methods, Biostatistics, Bioinformatics, and Collaborative Researches.
Dr. Chao Cheng is an Assistant Pofessor in Department of Genetics at Dartmouth College. He got his Ph.D. in Computational Biology and Bioinformatics at University of Southern California in 2007. He also has a M.S. degree in Molecular Genetics and a M.S. degree in Statistics. His Research Interests include Transcriptional Regulation underlying Human Diseases and Cancer, Methods for Next Generation Sequencing, Gene Regulatory Network and System Biology, Microarray Normalization and Data Analysis, MicroRNA and Cancer, Aging Study in Various Model Organisms.
Dr. Chao Cheng is an Assistant Pofessor in Department of Genetics at Dartmouth College. He got his Ph.D. in Computational Biology and Bioinformatics at University of Southern California in 2007. He also has a M.S. degree in Molecular Genetics and a M.S. degree in Statistics. His Research Interests include Transcriptional Regulation underlying Human Diseases and Cancer, Methods for Next Generation Sequencing, Gene Regulatory Network and System Biology, Microarray Normalization and Data Analysis, MicroRNA and Cancer, Aging Study in Various Model Organisms.
Dr. Chen is an Assistant Professor and a Member of the Cancer Epigenetics Program and the Personalized Risk and Prevention Keystone Program at FCCC. His laboratory is focused on molecular characterization of pre-invasive cancerous lesions with different 'aggressiveness' by genome-wide approach [e.g., global differential allele-specific expression analysis (DASE)]. His long-term research goal is to identify differences among normal, pre-malignant and cancerous breast tissue, determine their consequences, and use this information to improve cancer patient care.
Dr. Chen is an Assistant Professor and a Member of the Cancer Epigenetics Program and the Personalized Risk and Prevention Keystone Program at FCCC. His laboratory is focused on molecular characterization of pre-invasive cancerous lesions with different 'aggressiveness' by genome-wide approach [e.g., global differential allele-specific expression analysis (DASE)]. His long-term research goal is to identify differences among normal, pre-malignant and cancerous breast tissue, determine their consequences, and use this information to improve cancer patient care.
Dr. Manoj N Krishnan obtained PhD from Mahatma Gandhi University (India) in Biophysics. After completing postdoctoral training in the application of genomics in infectious diseases at the Yale University (USA), he is currently an Assistant Professor of Infectious Diseases and Immunology at the Duke-NUS Graduate Medical School, Singapore. His area of research involves the discovery of genes and signaling modules regulating innate immune response, and viral infections, at a systems level. He is also interested in studying the mechanistic impact of natural mutations on immune signaling systems, as well as systems chemical genetics. His expertise spans across gene deletion (CRISPR)
Dr. Manoj N Krishnan obtained PhD from Mahatma Gandhi University (India) in Biophysics. After completing postdoctoral training in the application of genomics in infectious diseases at the Yale University (USA), he is currently an Assistant Professor of Infectious Diseases and Immunology at the Duke-NUS Graduate Medical School, Singapore. His area of research involves the discovery of genes and signaling modules regulating innate immune response, and viral infections, at a systems level. He is also interested in studying the mechanistic impact of natural mutations on immune signaling systems, as well as systems chemical genetics. His expertise spans across gene deletion (CRISPR) and knockdown (RNAi) based genetic screens, chemical genetics, and signaling pathway dissection in the context of immunity and infection.
Dr. Yong Song is a full time academic at the University of Western Australia. He graduated with M.D. degree and Master degree in Clinical Medicine in China in 1999. He subsequently pursued PhD studies with APAI scholarship and undertook a postdoctoral position at School of Molecular and Biomedical Sciences, Murdoch University, Australia. Since 2010, he was appointed Assistant Professor in the School of Anatomy, Physiology & Human Biology,the University of Western Australia. His research focused on the neonatal respiratory biology. He is particularly interested in the molecular mechanisms underlying functional and phenotypic changes of the neonatal respiratory system in response
Dr. Yong Song is a full time academic at the University of Western Australia. He graduated with M.D. degree and Master degree in Clinical Medicine in China in 1999. He subsequently pursued PhD studies with APAI scholarship and undertook a postdoctoral position at School of Molecular and Biomedical Sciences, Murdoch University, Australia. Since 2010, he was appointed Assistant Professor in the School of Anatomy, Physiology & Human Biology,the University of Western Australia. His research focused on the neonatal respiratory biology. He is particularly interested in the molecular mechanisms underlying functional and phenotypic changes of the neonatal respiratory system in response to prenatal and postnatal injuries. He has extensive experience in developmental regulation, molecular signalling, cellular pathways, oxidative stress, epigenetic regulation and mitochondrial dysfunction, which render him capable of deciphering the fundamental mechanisms of newborn respiratory diseases.
Dr. Fabio Caradonna was born in Erice (TP) on July 31, 1964. Since 2004, he works as University Researcher of Genetics, Assistant professor of Human genetics and Cytogenetics at the University of Palermo, Italy. He is proponent, principal investigator and coordinator of one of the Italian research units of the project of research: Hepatotoxicity induced by high-dose treatments in tuberculosis: analysis of the VNTR polymorphisms of CYP2E1 gene in patients and study of possible pathogenetic involvement of Aquaporin-9, funded by the Italian Interuniversity Consortium for Argentina (CUIA). His research interests in clude Genetics and Cytogenetics; Genotoxicity assay of xenobiotics;
Dr. Fabio Caradonna was born in Erice (TP) on July 31, 1964. Since 2004, he works as University Researcher of Genetics, Assistant professor of Human genetics and Cytogenetics at the University of Palermo, Italy. He is proponent, principal investigator and coordinator of one of the Italian research units of the project of research: Hepatotoxicity induced by high-dose treatments in tuberculosis: analysis of the VNTR polymorphisms of CYP2E1 gene in patients and study of possible pathogenetic involvement of Aquaporin-9, funded by the Italian Interuniversity Consortium for Argentina (CUIA). His research interests in clude Genetics and Cytogenetics; Genotoxicity assay of xenobiotics; Genotyping of genic polymorphisms by RT-PCR with Taqman chemistry; Protein Chromosome Immunolocalization;DNA and Chromosome methylation status techniques
Dr. Nikolay A Barashkov - PhD, scientific researcher in Department of Molecular Genetics, Yakut Scientific Centre of Complex Medical Problems, Siberian Branch of the Russian Academy of Medical Sciences (Yakutsk, Sakha Republic, Russian Federation), scientific researcher in Laboratory of Molecular Biology, Institute of Natural Sciences, M.K. Ammosov North-Eastern Federal University (Yakutsk, Sakha Republic, Russian Federation). His research interest focused in genetics of sensory disorders. His research is supported by grants from Russian Foundation of Basic Research (RFBR).
Dr. Nikolay A Barashkov - PhD, scientific researcher in Department of Molecular Genetics, Yakut Scientific Centre of Complex Medical Problems, Siberian Branch of the Russian Academy of Medical Sciences (Yakutsk, Sakha Republic, Russian Federation), scientific researcher in Laboratory of Molecular Biology, Institute of Natural Sciences, M.K. Ammosov North-Eastern Federal University (Yakutsk, Sakha Republic, Russian Federation). His research interest focused in genetics of sensory disorders. His research is supported by grants from Russian Foundation of Basic Research (RFBR).
Dr. Debnath has obtained Ph.D. in Biological Sciences from University of North Bengal, Siliguri, India and worked in the field of Psychiatric Immunogenetics. He has also worked as a Postdoctoral Fellow in Kunming Institute of Zoology, Kunming, China and St. Louis Hospital, Paris and Mondor Institute of Biomedical Research, Creteil, France. During his postdoc, he has worked on population genomics as well as Psychiatric Genetics. Currently, Dr. Debnath is working as Assistant Professor in the Department of Human Genetics, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India. His current research interests are Immunogenetic understanding of Psychiatric
Dr. Debnath has obtained Ph.D. in Biological Sciences from University of North Bengal, Siliguri, India and worked in the field of Psychiatric Immunogenetics. He has also worked as a Postdoctoral Fellow in Kunming Institute of Zoology, Kunming, China and St. Louis Hospital, Paris and Mondor Institute of Biomedical Research, Creteil, France. During his postdoc, he has worked on population genomics as well as Psychiatric Genetics. Currently, Dr. Debnath is working as Assistant Professor in the Department of Human Genetics, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India. His current research interests are Immunogenetic understanding of Psychiatric Disorders and Guillain Barré Syndrome (GBS).
Dr. Chen is a Research Horticulturist leading a stone fruit genetics, genomics, and breeding program at the USDA, ARS, Southeastern Fruit and Tree Nut Research Laboratory. The Chen laboratory is focused on understanding of some important genes and pathways using multiple functional genomics tools such as microarray, next-generation sequencing, quantitative PCR, and map-based cloning. His long-term goal is to improve stone fruit varieties for the industry through conventional hybridization and genomics-assisted approaches.
Dr. Chen is a Research Horticulturist leading a stone fruit genetics, genomics, and breeding program at the USDA, ARS, Southeastern Fruit and Tree Nut Research Laboratory. The Chen laboratory is focused on understanding of some important genes and pathways using multiple functional genomics tools such as microarray, next-generation sequencing, quantitative PCR, and map-based cloning. His long-term goal is to improve stone fruit varieties for the industry through conventional hybridization and genomics-assisted approaches.
Dr. Wakabayashi is a Team Leader at Division of Experimental Animal Research, Department of Carcinogenesis Research, Chiba Cancer Research Institute in Japan. His laboratory is focusing on mouse models of human cancer, mainly using multistep carcinogenesis model of skin tumors induced by two chemicals, DMBA and TPA. His long-term research goal is to identify genetic factors conferring resistance to skin tumors. In addition, his laboratory is trying to identify the role of epidermal stem cells in skin carcinogenesis model.
Dr. Wakabayashi is a Team Leader at Division of Experimental Animal Research, Department of Carcinogenesis Research, Chiba Cancer Research Institute in Japan. His laboratory is focusing on mouse models of human cancer, mainly using multistep carcinogenesis model of skin tumors induced by two chemicals, DMBA and TPA. His long-term research goal is to identify genetic factors conferring resistance to skin tumors. In addition, his laboratory is trying to identify the role of epidermal stem cells in skin carcinogenesis model.
Haris Kokotas, Molecular Geneticist, received his BSc from the Faculty of Biology, University of Athens, Greece and earned his PhD in Molecular Genetics of Deafness from the Athens University Medical School. He has gained experience on cytogenetic and molecular techniques and he has focused his research on the genetics of the head, including hearing loss and eye diseases. He is currently the principal investigator or co-investigator in several research projects which are being performed at the Department of Genetics, Institute of Child Health, Athens, Greece. Haris is a member of the Hellenic Association of Medical Geneticists, the European Society of
Haris Kokotas, Molecular Geneticist, received his BSc from the Faculty of Biology, University of Athens, Greece and earned his PhD in Molecular Genetics of Deafness from the Athens University Medical School. He has gained experience on cytogenetic and molecular techniques and he has focused his research on the genetics of the head, including hearing loss and eye diseases. He is currently the principal investigator or co-investigator in several research projects which are being performed at the Department of Genetics, Institute of Child Health, Athens, Greece. Haris is a member of the Hellenic Association of Medical Geneticists, the European Society of Human Genetics (ESHG), and the American Society of Human Genetics (ASHG). His research interests include Molecular genetics of deafness and blindness.
Jainy Thomas is currently doing her post-doctoral research in the Department of Human Genetics at the University of Utah. After completing her masters in 2006, she joined for the doctoral program in the University of Texas at Arlington in 2007. She worked on mobile DNA and presented her research in several national and international meetings and has received many awards including travel grants. She graduated with a doctoral degree in 2010. She has published multiple papers in peer-reviewed journals and is aiming on setting up her own lab. Her research interest focuses on impact of transposable elements on the genome
Jainy Thomas is currently doing her post-doctoral research in the Department of Human Genetics at the University of Utah. After completing her masters in 2006, she joined for the doctoral program in the University of Texas at Arlington in 2007. She worked on mobile DNA and presented her research in several national and international meetings and has received many awards including travel grants. She graduated with a doctoral degree in 2010. She has published multiple papers in peer-reviewed journals and is aiming on setting up her own lab. Her research interest focuses on impact of transposable elements on the genome evolution.
Dr Varinderpal S Dhillon is a molecular geneticist/cytogeneticist, having worked in a variety of medical diagnostics and research organizations. He was awarded the higher education scholarship to pursue tertiary education after completing a BSc (Medical) from Guru Nanak Dev University, Amritsar, India. His PhD focussed on the genetic toxicology and carcinogenesis aspects of various hormonal drugs. His expertise include Cancer, Nutrition, genome damage, genome instability, toxicology, infertility.
Dr Varinderpal S Dhillon is a molecular geneticist/cytogeneticist, having worked in a variety of medical diagnostics and research organizations. He was awarded the higher education scholarship to pursue tertiary education after completing a BSc (Medical) from Guru Nanak Dev University, Amritsar, India. His PhD focussed on the genetic toxicology and carcinogenesis aspects of various hormonal drugs. His expertise include Cancer, Nutrition, genome damage, genome instability, toxicology, infertility.
Dr. Gomez-Segui is currently working at the Hematology Department of the Hospital Universitari i Politecnic La Fe of Valencia (Spain). She received her M.D. in 2005 from the University of Valencia and then became hematologist following the hematology training program of the Hospital La Fe. She was awarded in 2010 with a national research grant of the Ministry of Economy and Competitiveness and developed her research program on hematologic diagnostic and cancer biology and genetics. She focused on the application of new technologies to study hematologic neoplasms during a stay at the Taussig Cancer Institute of the Cleveland Clinic (Ohio,
Dr. Gomez-Segui is currently working at the Hematology Department of the Hospital Universitari i Politecnic La Fe of Valencia (Spain). She received her M.D. in 2005 from the University of Valencia and then became hematologist following the hematology training program of the Hospital La Fe. She was awarded in 2010 with a national research grant of the Ministry of Economy and Competitiveness and developed her research program on hematologic diagnostic and cancer biology and genetics. She focused on the application of new technologies to study hematologic neoplasms during a stay at the Taussig Cancer Institute of the Cleveland Clinic (Ohio, USA) in 2012. She has participated in several research projects supported by public and private fundings. Her major research interest is on the discovery of new acquired genetic aberrations in cancer cells through microarrays and next-generation sequencing technologies.
I am associated professor in the Department of Chemistry and Biochemistry at University of Zagreb, Faculty of Food Technology and Biotechnology. My PhD work (University of Zagreb) was focused on investigation of interaction among different cell wall constituents, particularly interactions that may be responsible for the incorporation of proteins into cell wall of yeast Saccharomyces cerevisiae. During my postdoctoral work at CNRS (Centre national de la recherche scientifique) in France my main goal was to better understand role of different proteins as well as protein interactions that are part of quality control machinery. During postdoctoral work at INSERM (Institute national
I am associated professor in the Department of Chemistry and Biochemistry at University of Zagreb, Faculty of Food Technology and Biotechnology. My PhD work (University of Zagreb) was focused on investigation of interaction among different cell wall constituents, particularly interactions that may be responsible for the incorporation of proteins into cell wall of yeast Saccharomyces cerevisiae. During my postdoctoral work at CNRS (Centre national de la recherche scientifique) in France my main goal was to better understand role of different proteins as well as protein interactions that are part of quality control machinery. During postdoctoral work at INSERM (Institute national de la santa et de la recherche medicale) in France I was involved in developmental research with focus on regulation of meiosis by transcription. My current interests lie in understanding the transcription regulation of cell wall proteins, development of new yeast strains and their using in biotechnological industry.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97